Evaluation of myocardial performance index in patients with COVID-19: An echocardiographic follow-up study

被引:5
|
作者
Kaya, Hakan [1 ]
Asoglu, Ramazan [1 ]
Afsin, Abdulmecit [2 ]
Tibilli, Hakan [2 ]
Kurt, Ercan [3 ]
Kafadar, Safiye [4 ]
Gulacti, Umut [5 ]
Kafadar, Huseyin [6 ]
机构
[1] Adiyaman Training & Res Hosp, Dept Cardiol, Adiyaman, Turkey
[2] Kahta State Hosp, Dept Cardiol, Adiyaman, Turkey
[3] Adiyaman Training & Res Hosp, Dept Otorhinolaryngol, Adiyaman, Turkey
[4] Adiyaman Training & Res Hosp, Dept Radiol, Adiyaman, Turkey
[5] Adiyaman Training & Res Hosp, Dept Emergency, Adiyaman, Turkey
[6] Adiyaman Univ, Fac Med, Dept Fores Med, Adiyaman, Turkey
关键词
COVID-19; Echocardiography; Myocardial performance index; EUROPEAN ASSOCIATION; AMERICAN SOCIETY; EARLY-DIAGNOSIS; CORONAVIRUS; DISEASE; HEART; RECOMMENDATIONS; INFARCTION; OUTBREAK; UPDATE;
D O I
10.1016/j.repc.2021.03.014
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction and Objectives: Myocardial performance may be impaired in cytokine-mediated immune reactions. The myocardial performance index (MPI) is a practical parameter that reflects systolic and diastolic cardiac function. We aimed to assess the MPI in patients with COVID-19. Methods: The study population consisted of 40 healthy controls and 40 patients diagnosed with COVID-19 who had mild pneumonia and did not need intensive care treatment. All participants underwent echocardiographic examination. First, the MPI and laboratory parameters were compared between healthy controls and patients in the acute period of infection. Second, the MPI and laboratory parameters were compared between the acute infection period and after clinical recovery. Results: Compared with healthy controls, patients with COVID-19 had a significantly higher MPI (0.56 +/- 0.09 vs. 0.41 +/- 0.06, p<0.001), longer isovolumic relaxation time (IRT) (112.3 +/- 13.4 vs. 90.6 +/- 11.2 ms, p<0.001), longer deceleration time (DT) (182.1 +/- 30.6 vs. 160.8 +/- 42.7 ms, p=0.003), shorter ejection time (ET) (279.6 +/- 20.3 vs. 299.6 +/- 34.7 ms, p<0.001) and higher E/A ratio (1.53 +/- 0.7 vs. 1.21 +/- 0.3, p<0.001). Statistically significantly higher MPI (0.56 +/- 0.09 vs. 0.44 +/- 0.07, p<0.001), longer IRT (112.3 +/- 13.4 vs. 91.8 +/- 12.1 ms, p<0.001), longer DT (182.1 +/- 30.6 vs. 161.5 +/- 43.5 ms, p=0.003), shorter ET 279.6 +/- 20.3 vs. 298.8 +/- 36.8 ms, p<0.001) and higher E/A ratio (1.53 +/- 0.7 vs. 1.22 +/- 0.4, p<0.001) were observed during the acute infection period than after clinical recovery. Left ventricular ejection fraction was similar in the controls, during the acute infection period and after clinical recovery. Conclusions: Subclinical diastolic impairment without systolic involvement may be observed in patients with COVID-19. This impairment may be reversible on clinical recovery. (C) 2022 Sociedade Portuguesa de Cardiotogia. Published by Elsevier Espana, S.L.U.
引用
收藏
页码:455 / 461
页数:7
相关论文
共 50 条
  • [21] Evaluation of 3-month follow-up of patients with postacute COVID-19 syndrome
    Kerget, Bugra
    Celik, Eda
    Kerget, Ferhan
    Aksakal, Alperen
    Ucar, Elif Yilmazel
    Araz, Omer
    Akgun, Metin
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (05) : 2026 - 2034
  • [22] Pharmacovigilance follow-up of patients in the context of the COVID-19 pandemic
    Grandvuillemin, Aurelie
    Rocher, Fanny
    Valnet-Rabier, Marie Blanche
    Drici, Milou-Daniel
    French Pharmacovigilance Network
    THERAPIE, 2023, 78 (05): : 523 - 529
  • [23] Follow-up of COVID-19 convalescent patients by the general practitioner
    不详
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2020, 204 (08): : 769 - 769
  • [24] Follow-up of COVID-19 recovered patients with mild disease
    Alina Kashif
    Manahil Chaudhry
    Tehreem Fayyaz
    Mohammad Abdullah
    Ayesha Malik
    Javairia Manal Akmal Anwer
    Syed Hashim Ali Inam
    Tehreem Fatima
    Noreena Iqbal
    Khadija Shoaib
    Scientific Reports, 11
  • [25] Follow-up studies in COVID-19 recovered patients - is it mandatory?
    Balachandar, Updates Vellingiri
    Mahalaxmi, Iyer
    Subramaniam, Mohandevi
    Kaavya, Jayaramayya
    Kumar, Nachimuthu Senthil
    Laldinmawii, Gracy
    Narayanasamy, Arul
    Reddy, Patur Janardhana Kumar
    Sivaprakash, Palanisamy
    Kanchana, Sivaprakash
    Vivekanandhan, Govindasamy
    Cho, Ssang-Goo
    SCIENCE OF THE TOTAL ENVIRONMENT, 2020, 729
  • [26] Follow-up of COVID-19 recovered patients with mild disease
    Kashif, Alina
    Chaudhry, Manahil
    Fayyaz, Tehreem
    Abdullah, Mohammad
    Malik, Ayesha
    Anwer, Javairia Manal Akmal
    Inam, Syed Hashim Ali
    Fatima, Tehreem
    Iqbal, Noreena
    Shoaib, Khadija
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [27] Is ECG follow-up necessary in hypertensive patients with COVID-19?
    Bahat, Kubra Aydin
    Aydin, Gulay
    KUWAIT MEDICAL JOURNAL, 2023, 55 (03): : 218 - 223
  • [28] Follow-up of convalescent COVID-19 patients by the general practitioner
    不详
    BULLETIN DE L ACADEMIE NATIONALE DE MEDECINE, 2020, 204 (09): : E92 - E92
  • [29] COVID-19 in Children: Clinical Characteristics and Follow-Up Study
    Pei-sen Ruan
    Hui-qing Xu
    Jun-hua Wu
    Qi-fa Song
    Hai-yan Qiu
    SN Comprehensive Clinical Medicine, 2020, 2 (10) : 1713 - 1716
  • [30] Long COVID = late follow-up to COVID-19
    Faiz, Kashif Waqar
    TIDSSKRIFT FOR DEN NORSKE LAEGEFORENING, 2021, 141 (16) : 1558 - 1558